Clinical trials
Phase 3 Nephrotic Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 3 |
| Not yet recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Hospital of Fudan University | 4 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Nilratan Sircar Medical College | 2 |
| Sun Yat-sen University | 2 |
| All India Institute of Medical Sciences | 1 |
| Asahi Kasei Therapeutics Corporation | 1 |
| Emory University | 1 |
| Hoffmann-La Roche | 1 |
| Istituto Giannina Gaslini | 1 |
| Mao Jianhua | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nephrotic Syndrome | 24 |
| Nephrosis, Lipoid | 4 |
| Edema | 1 |
| Glomerulosclerosis, Focal Segmental | 1 |
| Hypernatremia | 1 |
| Kidney Diseases | 1 |
| Pathologic Complete Response | 1 |
| Proteinuria | 1 |
| Recurrence | 1 |
Trials
Showing 51 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.